Treatment of chronic inflammatory disorders of the gastrointestinal tract
US5863910A · kind A · utility
39Cited by
1References
19Claims
0Family size
Inventors
Key dates
| Filing date | Oct 21, 1997 |
| Grant date | Jan 26, 1999 |
| Priority date | — |
| Expiry date | Oct 21, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to an oral formulation for treating gastrointestinal inflammation that includes an effective amount of budesonide suspended in an edible oil, typically a vegetable oil. A method for treating gastrointestinal inflammation in mammals is also described and includes orally administering a composition of this invention to a mammal. In one embodiment, an initial dosage is administered daily for about two to four weeks and the dosage is subsequently tapered, generally at about two week intervals, in response to a reduction in symptoms until a minimum dose that controls symptoms is achieved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.